Propanc Biopharma's total assets for Q2 2026 were $15.11M, a decrease of -15.93% from the previous quarter. PPCB total liabilities were $4.66M for the fiscal quarter, a 28.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.